Drug General Information
Drug ID	D0X6PH
Former ID	DNC013421
Drug Name	5-(6-hydroxy-2-naphthyl)-1,2,3-benzenetriol
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[531026]
Structure		Download 2D MOL 3D MOL
Formula	C16H12O4
Canonical SMILES	C1=CC2=C(C=CC(=C2)O)C=C1C3=CC(=C(C(=C3)O)O)O
InChI	1S/C16H12O4/c17-13-4-3-9-5-10(1-2-11(9)6-13)12-7-14(18)16(20)15(19)8-12/h1-8,17-20H
InChIKey	PBTSXIZGBMXUHW-UHFFFAOYSA-N
PubChem Compound ID	25062609
Target and Pathway
Target(s)	Tyrosine oxidase	Target Info	Inhibitor	[531026]
BioCyc Pathway	(S)-reticuline biosynthesis
	Eumelanin biosynthesis
	L-dopachrome biosynthesis
KEGG Pathway	Tyrosine metabolism
	Riboflavin metabolism
	Metabolic pathways
	Melanogenesis
PathWhiz Pathway	Riboflavin Metabolism
	Tyrosine Metabolism
WikiPathways	Dopamine metabolism
References
Ref 531026	Bioorg Med Chem Lett. 2010 Aug 15;20(16):4882-4. Epub 2010 Jun 19.A newly synthesized, potent tyrosinase inhibitor: 5-(6-hydroxy-2-naphthyl)-1,2,3-benzenetriol.
Ref 531026	Bioorg Med Chem Lett. 2010 Aug 15;20(16):4882-4. Epub 2010 Jun 19.A newly synthesized, potent tyrosinase inhibitor: 5-(6-hydroxy-2-naphthyl)-1,2,3-benzenetriol.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.